PMVPPMV Pharmaceuticals, Inc.
1.330USD+3.91%Mkt Cap: 71.10M $P/E: —3d ago
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezata…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap71.10M $
Enterprise Value-26.06M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-77.74M $
Revenue/Share—
Last Price1.330 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees54
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.14
PEG—
EV/EBITDA0.31
EV/Revenue—
P/S—
P/B0.66
EPS (TTM)-1.45
EPS (Forward)-1.15
52W Range
1.02036% of range1.880
52W High1.880 USD
52W Low1.020 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-74.24%
ROA-66.70%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-73.58M $
CapEx (TTM)29.00K $
FCF Margin—
FCF Yield-65.53%
Net Debt-93.26M $
Net Debt/EBITDA1.12
Balance Sheet
Debt/Equity0.01
Current Ratio11.14
Quick Ratio10.88
Book Value/Sh1.963 USD
Cash/Share1.754 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.000 USD
Upside (mean)+200.8%
Target Range3.000 USD – 5.000 USD
$3.000+200.8% to mean$5.000
# Analysts4
Ownership
Shares Out.53.46M
Float46.20M
Insiders3.35%
Institutions64.72%
Short Interest
Short Ratio7.8d
Short % Float4.61%
Short % Out.4.46%
Shares Short2.38M
Short (prev mo.)2.91M
Technical
SMA 501.215 (+9.5%)
SMA 2001.272 (+4.6%)
Beta1.35
S&P 52W Chg18.16%
Avg Vol (30d)327.68K
Avg Vol (10d)203.57K
Technical Indicators
RSI (14)59.9
MACD0.0153
MACD Signal0.0008
MACD Hist.+0.0145
BB Upper1.359 USD
BB Middle1.206 USD
BB Lower1.053 USD
BB Width25.35%
ATR (14)0.0699 USD
Vol Ratio (20d)0.36x